AG000IYQ

1195768-06-9 | Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1)

Chemical structure of Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1), CAS 1195768-06-9
AG000IYQ
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 1195768-06-9
Catalog Number AG000IYQ(AGN-PC-0WAMC2)
Chemical Name Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1)
IUPAC Name N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;methanesulfonic acid
InChI InChI=1S/C23H20F3N5O2S2.CH4O3S/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25;1-5(2,3)4/h4-11,31H,1-3H3,(H2,27,28,29);1H3,(H,2,3,4)
InChI Key YKGMKSIHIVVYKY-UHFFFAOYSA-N
MDL Number MFCD20922872
Molecular Formula C24H24F3N5O5S3
Molecular Weight 615.6681
SMILES O=S(C1=C(F)C=CC=C1F)(NC2=CC=CC(C3=C(C4=NC(N)=NC=C4)SC(C(C)(C)C)=N3)=C2F)=O.CS(=O)(O)=O
UNII B6DC89I63E
Synonyms
Dabrafenib mesylate, 1195768-06-9, UNII-B6DC89I63E, Dabrafenib (Mesylate), GSK 2118436B, METHANE SULFONATE SALT, Dabrafenib mesylate [USAN], B6DC89I63E, CHEBI:75048, GSK2118436B, GSK-2118436B, Dabrafenib Mesylate (GSK-2118436B), Dabrafenib Mesylate (GSK-2118436), Dabrafenib mesylate (USAN), Taflinar, N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate, GSK-2118436A, Dabrafenib methanesulfonate, Tafinlar (TN), GSK2118436 Methane sulfonate salt, dabrafenib monomesylate, Dabrafenib mesilate (JAN), GSK2118436 Mesylate, GSK 2118436 Mesylate, SCHEMBL1127269, CHEMBL2105729, DTXSID70152500, YKGMKSIHIVVYKY-UHFFFAOYSA-N, AOB87316, BCP04738, EX-A1559, HY-14660A, MFCD20922872, AKOS025396661, API0024336, CS-1641, Dabrafenib Mesylate(GSK-2118436B), KS-00000T33, AK174048, AS-17010, SC-14698, AK00739757, FT-0696677, D10104, SR-01000941590, SR-01000941590-1, GSK2118436 Ms salt, Dabrafenib Ms salt, GSK2118436A Ms salt, Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1), N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;methanesulfonic acid, N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide methanesulfonate, N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide methanesulfonate, Tafinlar, (R)-Monophos, GSK 2118436, 1195768-06-9 (mesylate), ACN-041337, GSK-2118436, A15059,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited